Candel Therapeutics (CADL) Short term Debt (2020 - 2023)
Candel Therapeutics' Short term Debt history spans 2 years, with the latest figure at $6.1 million for Q3 2023.
- For Q3 2023, Short term Debt changed N/A year-over-year to $6.1 million; the TTM value through Sep 2023 reached $6.1 million, changed N/A, while the annual FY2020 figure was $463000.0, N/A changed from the prior year.
- Short term Debt for Q3 2023 was $6.1 million at Candel Therapeutics, up from $3.7 million in the prior quarter.
- Across five years, Short term Debt topped out at $6.1 million in Q3 2023 and bottomed at $463000.0 in Q4 2020.